Acute myeloid leukemia: 2023 update on diagnosis, risk‐stratification, and management
Disease overview Acute myeloid leukemia (AML) is a frequently fatal bone marrow stem cell
cancer characterized by unbridled proliferation of malignant marrow stem cells with …
cancer characterized by unbridled proliferation of malignant marrow stem cells with …
NPM1-mutated acute myeloid leukemia: from bench to bedside
The nucleophosmin (NPM1) gene encodes for a multifunctional protein with prominent
nucleolar localization that shuttles between nucleus and cytoplasm. NPM1 mutations …
nucleolar localization that shuttles between nucleus and cytoplasm. NPM1 mutations …
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
The classification of myeloid neoplasms and acute leukemias was last updated in 2016
within a collaboration between the World Health Organization (WHO), the Society for …
within a collaboration between the World Health Organization (WHO), the Society for …
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
The 2010 and 2017 editions of the European LeukemiaNet (ELN) recommendations for
diagnosis and management of acute myeloid leukemia (AML) in adults are widely …
diagnosis and management of acute myeloid leukemia (AML) in adults are widely …
Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal
E Estey, RP Hasserjian… - Blood, The Journal of the …, 2022 - ashpublications.org
Patients with acute myeloid leukemia (AML) have conventionally received more intense
therapy than patients with myelodysplastic syndrome (MDS). Although less intense …
therapy than patients with myelodysplastic syndrome (MDS). Although less intense …
The International Consensus Classification of acute myeloid leukemia
Acute myeloid leukemias (AMLs) are overlapping hematological neoplasms associated with
rapid onset, progressive, and frequently chemo-resistant disease. At diagnosis, classification …
rapid onset, progressive, and frequently chemo-resistant disease. At diagnosis, classification …
Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia
B Falini, MP Martelli - American Journal of Hematology, 2023 - Wiley Online Library
Several editions of the World Health Organization (WHO) classifications of lympho‐
hemopoietic neoplasms in 2001, 2008, and 2016 served as the international standard for …
hemopoietic neoplasms in 2001, 2008, and 2016 served as the international standard for …
Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia
RP Hasserjian, DP Steensma… - Blood, The Journal …, 2020 - ashpublications.org
Current objectives regarding treatment of acute myeloid leukemia (AML) include achieving
complete remission (CR) by clinicopathological criteria followed by interrogation for the …
complete remission (CR) by clinicopathological criteria followed by interrogation for the …
Comparison of the revised 4th (2016) and 5th (2022) editions of the World Health Organization classification of myelodysplastic neoplasms
Y Zhang, J Wu, T Qin, Z Xu, S Qu, L Pan, B Li, H Wang… - Leukemia, 2022 - nature.com
We used data from 852 consecutive subjects with myelodysplastic neoplasms (MDS)
diagnosed according to the 2016 (revised 4th) World Health Organization (WHO) criteria to …
diagnosed according to the 2016 (revised 4th) World Health Organization (WHO) criteria to …
How I diagnose and treat NPM1-mutated AML
B Falini, L Brunetti, MP Martelli - Blood, The Journal of the …, 2021 - ashpublications.org
Mutations of the nucleophosmin (NPM1) gene, encoding for a nucleolar multifunctional
protein, occur in approximately one-third of adult acute myeloid leukemia (AML). NPM1 …
protein, occur in approximately one-third of adult acute myeloid leukemia (AML). NPM1 …